Loading cancer entity…
Loading cancer entity…
Clinical trials
210 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (32)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT02993159 | Testing an Active Form of Tamoxifen (4-hydroxytamoxifen) Delivered Through Breast Skin to Control Ductal Carcinoma in Situ (DCIS) of the Breast | completed | Phase 2 | 100 | Northwestern UniversityOTHER | 1 | Dec 18, 2024 | clinicaltrials |
| NCT06677944 | Preoperative Partial Breast Irradiation in Early-Stage Breast Cancer | recruiting | Phase 2 | 47 | Yonsei UniversityOTHER | 1 | Nov 7, 2024 | clinicaltrials |
| NCT04049214 |
| Perioperative Mindfulness Proposal |
| recruiting |
| N/A |
| 24 |
| Hoag Memorial Hospital PresbyterianOTHER |
| 1 |
| Oct 15, 2024 |
| clinicaltrials |
| NCT04245150 | Assessing the Impact of the Microbiome on Breast Cancer Radiotherapy Toxicity | completed | — | 23 | Case Comprehensive Cancer CenterOTHER | 1 | Sep 19, 2024 | clinicaltrials |
| NCT01706432 | Hypofractionated Image Guided Radiation Therapy in Treating Patients With Stage IV Breast Cancer | completed | — | 4 | University of ChicagoOTHER | 1 | Jul 31, 2024 | clinicaltrials |
| NCT02876640 | Retinoid 9cUAB30 in Producing a Biologic Effect in Patients With Early Stage Breast Cancer | terminated | Phase 1 | 27 | National Cancer Institute (NCI)NIH | 1 | Jun 18, 2024 | clinicaltrials |
| NCT04422366 | Evaluate the Efficacy, Immunogenicity and Safety of 9-valent HPV Recombinant Vaccine in Chinese Healthy Females | recruiting | Phase 3 | 8,000 | Shanghai Bovax Biotechnology Co., Ltd.INDUSTRY | 1 | Jun 7, 2024 | clinicaltrials |
| NCT06401304 | Oncologic, Cosmetic and Patient Reported Outcomes in Value-Based Breast Surgery (OnCoPRO Value)(OncoPROValue-1) | recruiting | — | 1,200 | Uppsala UniversityOTHER | 3 | May 6, 2024 | clinicaltrials |
| NCT06393543 | International Registration of Isolated STIC: to Report and Investigate the Risk of Serous Peritoneal Carcinomatosis(STICRISC) | not yet recruiting | — | 600 | Radboud University Medical CenterOTHER | 0 | May 1, 2024 | clinicaltrials |
| NCT04895020 | Immunobridging Study of 9-valent Human Papillomavirus Recombinant Vaccine in Chinese Females Aged 9 to 19 Years | unknown | Phase 3 | 1,200 | Shanghai Bovax Biotechnology Co., Ltd.INDUSTRY | 1 | Apr 17, 2024 | clinicaltrials |
| NCT04603209 | Registry for Intra-Operative Radiotherapy During Breast Conserving Surgery in Patients With Early Stage Breast Cancer | recruiting | — | 1,000 | Saint John's Cancer InstituteOTHER | 1 | Apr 16, 2024 | clinicaltrials |
| NCT02240836 | Energy Balance and Breast Cancer Aspects-II(EBBA-II) | active not recruiting | N/A | 545 | Oslo University HospitalOTHER | 1 | Apr 8, 2024 | clinicaltrials |
| NCT05946759 | Reoperation Rate in Breast-Conserving Surgery Using Confocal Histolog® Scanner for Intraoperative Margin Assessment(SHIELD) | completed | N/A | 54 | SamanTree Medical SAINDUSTRY | 1 | Mar 21, 2024 | clinicaltrials |
| NCT05613283 | Primary Cervical Cancer Screening by Self-sampling HPV Test(PREVENT) | active not recruiting | — | 17,875 | Peking University People's HospitalOTHER | 1 | Dec 21, 2023 | clinicaltrials |
| NCT02636582 | Nelipepimut-S Plus GM-CSF Vaccine Therapy in Treating Patients With Breast Cancer | completed | Phase 2 | 43 | National Cancer Institute (NCI)NIH | 1 | Dec 5, 2023 | clinicaltrials |
| NCT05372016 | Evaluate the Immunogenicity and Safety of 9-valent HPV Recombinant Vaccine in Chinese Healthy Females | completed | Phase 3 | 1,200 | Shanghai Bovax Biotechnology Co., Ltd.INDUSTRY | 1 | Nov 24, 2023 | clinicaltrials |
| NCT02937155 | In the Era of the HPV Vaccine, What Are The Current HPV Subtypes Contributing to High Grade Cervical Dysplasia, Adenocarcinoma in Situ, and Early Cervical Cancer? | unknown | — | 100 | Sunnybrook Health Sciences CentreOTHER | 1 | Nov 22, 2023 | clinicaltrials |
| NCT01219075 | Soy Isoflavones Supplementation in Treating Women at High Risk For or With Breast Cancer | completed | N/A | 110 | University of Southern CaliforniaOTHER | 1 | Nov 18, 2023 | clinicaltrials |
| NCT02127073 | Pilot Study of Oxytocin and microRNA Identification in NAF, Serum, and Tissue in Women With Breast Cancer | terminated | Phase 2 | 8 | Montefiore Medical CenterOTHER | 1 | Nov 9, 2023 | clinicaltrials |
| NCT05436808 | Partial Chest Wall Radiation Therapy After Surgery for Lymph Node Negative Breast Cancer | withdrawn | Early Phase 1 | 0 | Stony Brook UniversityOTHER | 1 | Oct 18, 2023 | clinicaltrials |
| NCT05032079 | Subzero and Scorpion Trial | withdrawn | N/A | 0 | Larkin Community HospitalOTHER | 1 | Oct 16, 2023 | clinicaltrials |
| NCT01628536 | A Pilot Pre-operative Window Trial of Black Cohosh in Women With Ductal Carcinoma in Situ | completed | N/A | 33 | Yale UniversityOTHER | 1 | Oct 13, 2023 | clinicaltrials |
| NCT02637024 | Trial of Radiation Fractionation Schedules for Once-a-Day Accelerated Partial Breast Irradiation(OPAR) | completed | Phase 2 | 280 | Ontario Clinical Oncology Group (OCOG)OTHER | 1 | Aug 14, 2023 | clinicaltrials |
| NCT04022772 | Effect of PACK Health Support Program on Patient Reported Outcomes in Patients With Breast Cancer | completed | N/A | 287 | M.D. Anderson Cancer CenterOTHER | 1 | Aug 7, 2023 | clinicaltrials |
| NCT04722692 | Delayed Sentinel Lymph Node Biopsy in Ductal Cancer in Situ(SENTINOT_2) | recruiting | Phase 3 | 500 | Uppsala UniversityOTHER | 3 | Aug 3, 2023 | clinicaltrials |
| NCT05961280 | Selective Omission of Sentinel Lymph Node Biopsy in Mastectomy for Ductal Carcinoma in Situ: Identifying Eligible Candidates | completed | — | 385 | Gangnam Severance HospitalOTHER | 0 | Jul 27, 2023 | clinicaltrials |
| NCT05584332 | A Phase Ⅲ Study to Evaluate the Efficacy, Immunogenicity, Safety of Quadrivalent HPV Recombinant Vaccine in Chinese Healthy Females | terminated | Phase 3 | 3,131 | Shanghai Bovax Biotechnology Co., Ltd.INDUSTRY | 1 | Jul 21, 2023 | clinicaltrials |
| NCT05932758 | Excisional Vacuum-Assisted Breast Biopsy | unknown | N/A | 300 | European Institute of OncologyOTHER | 1 | Jul 21, 2023 | clinicaltrials |
| NCT02121873 | The Breast Duct: Pilot Study of Genomic Sequencing of Exfoliated Ductal Cells Obtained Through Endoscopy and Lavage | completed | — | 6 | Atossa Therapeutics, Inc.INDUSTRY | 1 | Jul 20, 2023 | clinicaltrials |
| NCT02889458 | Hong Kong Breast Cancer Study | active not recruiting | — | 7,000 | The University of Hong KongOTHER | 1 | May 23, 2023 | clinicaltrials |
| NCT05868252 | Molecular Analysis of the Sloane Project | unknown | — | 1,500 | King's College LondonOTHER | 1 | May 22, 2023 | clinicaltrials |
| NCT02526498 | Accelerated Partial Breast Radiation Therapy Using High-Dose Rate Brachytherapy in Treating Patients With Early Stage Breast Cancer After Surgery(TRIUMPH-T) | completed | Phase 2 | 200 | Rutgers, The State University of New JerseyOTHER | 1 | May 15, 2023 | clinicaltrials |
| NCT05218044 | Cryoablation as a Minimally Invasive Alternative to Surgery for Managing Ductal Carcinoma In Situ(DCIS) | recruiting | N/A | 30 | Glendale Adventist Medical Center d/b/a Adventist Health GlendaleOTHER | 1 | Mar 3, 2023 | clinicaltrials |
| NCT02314156 | Transdermal or Oral Telapristone Acetate in Treating Patients Undergoing Mastectomy | completed | Phase 2 | 67 | Northwestern UniversityOTHER | 1 | Feb 22, 2023 | clinicaltrials |
| NCT05724758 | Patient Reported Outcomes After Oncoplastic Breast Conserving Surgery | unknown | — | 100 | Brust-Zentrum AGOTHER | 0 | Feb 13, 2023 | clinicaltrials |
| NCT04248179 | The Ultrasound-guided Multiple-injection Costotransverse Block for Mastectomy and Primary Reconstructive Surgery. | completed | Phase 4 | 36 | Zealand University HospitalOTHER | 1 | Feb 9, 2023 | clinicaltrials |
| NCT03775213 | Acceptability of Active Monitoring (AM) as a Treatment Option for Ductal Carcinoma in Situ (DCIS) | completed | N/A | 322 | Duke UniversityOTHER | 1 | Jan 30, 2023 | clinicaltrials |
| NCT03323658 | Bexarotene in Preventing Breast Cancer in Patients at High Risk for Breast Cancer | completed | Phase 1 | 24 | National Cancer Institute (NCI)NIH | 1 | Jan 10, 2023 | clinicaltrials |
| NCT04170920 | Pilot Study of a an App to Improve Medication Adherence in Breast Cancer Survivors Receiving AIs | completed | N/A | 62 | Indiana UniversityOTHER | 1 | Sep 14, 2022 | clinicaltrials |
| NCT04985032 | Accelerated Partial Breast Irradiation (APBI) Using Stereotactic Body Radiation Therapy (SBRT) | recruiting | — | 200 | RPCR, Inc.OTHER | 1 | Aug 5, 2022 | clinicaltrials |
| NCT04349111 | An Efficacy Study of the Xoft® Axxent® eBx® IORT System® "Lite" | withdrawn | N/A | 0 | Xoft, Inc.INDUSTRY | 0 | Aug 2, 2022 | clinicaltrials |
| NCT04666961 | Impact of Neoadjuvant Hormonal Therapy on the Surgical Management of Extensive Ductal Carcinomas in Situ(HORNEO01) | recruiting | Phase 2 | 262 | Institut Cancerologie de l'OuestOTHER | 1 | Apr 22, 2022 | clinicaltrials |
| NCT04425291 | Evaluate the Immunogenicity and Safety of 4-valent and 9-valent HPV Recombinant Vaccine in Chinese Healthy Females | completed | Phase 3 | 1,680 | Shanghai Bovax Biotechnology Co., Ltd.INDUSTRY | 1 | Feb 25, 2022 | clinicaltrials |
| NCT05210348 | Clinical Evaluation of Detection of High Risk HPV in Urine(Urine-hrHPV) | unknown | — | 1,000 | Peking University People's HospitalOTHER | 1 | Jan 27, 2022 | clinicaltrials |
| NCT04866992 | Prospective Registry Trial for Single Port Robot-assisted Nipple Sparing Mastectomy (SPrNSM)(SPrNSM) | completed | — | 10 | University of Texas Southwestern Medical CenterOTHER | 1 | Jan 21, 2022 | clinicaltrials |
| NCT01849250 | Study of Docosahexaenoic Acid (DHA) in Triple Negative Breast Cancer Survivors | completed | Phase 2 | 65 | National Cancer Institute (NCI)NIH | 1 | Dec 28, 2021 | clinicaltrials |
| NCT02137252 | Naltrexone RCT for Treatment-Emergent Fatigue in Patients Receiving Radiation Therapy for Breast Cancer | terminated | Phase 2 | 3 | Dana-Farber Cancer InstituteOTHER | 1 | Nov 16, 2021 | clinicaltrials |
| NCT04245657 | Factors Affecting Functionality in Breast Cancer Survivors | completed | — | 111 | Izmir Bakircay UniversityOTHER | 1 | Nov 8, 2021 | clinicaltrials |
| NCT03834532 | Living Well After Breast Surgery | completed | N/A | 17 | University of Texas at AustinOTHER | 1 | Nov 2, 2021 | clinicaltrials |
| NCT02909426 | The Mammography and Ultrasonography STudy for Breast Cancer Screening Effectiveness(MUST-BE) | unknown | — | 11,880 | Soonchunhyang University HospitalOTHER | 1 | Oct 7, 2021 | clinicaltrials |
Data updated 22 days agoSource updated Dec 18, 2024source: clinicaltrials